Jiri Zavadil

Dr. Jiri Zavadil

International Agency For Research On Cancer, Lyon, Auvergne-Rhône-Alpes, France
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2012 in Nature
Verified
Journal Article
Closed access
PDF file
ICIlseung Cho
Ilseung Cho
SYShingo Yamanishi
Shingo Yamanishi
LCLaura Cox
Laura Cox
BMBarbara A. Methé
Barbara A. Methé
JZJiri Zavadil
Jiri Zavadil
MBMartin J. Blaser
Martin J. Blaser

29 August 2005 in Oncogene
Verified
Journal Article
Open access
PDF file
JZJiri Zavadil
Jiri Zavadil
EBErwin P Böttinger
Erwin P Böttinger
Remarkable phenotype plasticity of epithelial cells underlies morphogenesis, epithelial repair and tumor invasiveness. Detailed understanding of the contextual cues and molecular mediators that control epithelial plasticity will be required in order to develop viable therapeutic approaches targeting epithelial-to-mesenchymal transition (EMT), an advanced manifestation of epithelial plasticity. Members of the transforming growth factor (TGF-β) family of growth factors can initiate and maintain EMT in a variety of biological systems and pathophysiological context by activating major signaling pathways and transcriptional regulators integrated in extensive signaling networks. Here we will review the distinct physiological contexts of EMT and the underlying molecular signaling networks controlled by TGF-β.

1 July 2011 in Cancer Cell
Verified
Journal Article
Closed access
KMKelly Moran-Crusio
Kelly Moran-Crusio
LRLinsey Reavie
Linsey Reavie
ASAlan Shih
Alan Shih
OAOmar Abdel-Wahab
Omar Abdel-Wahab
DNDelphine Ndiaye-Lobry
Delphine Ndiaye-Lobry
RLRoss L. Levine
Ross L. Levine

1 November 2008 in Molecular Cell
Verified
Journal Article
Closed access
RMRaphael Margueron
Raphael Margueron
GLGuohong Li
Guohong Li
KSKavitha Sarma
Kavitha Sarma
ABAlexandre Blais
Alexandre Blais
JZJiri Zavadil
Jiri Zavadil
DRDanny Reinberg
Danny Reinberg

22 June 2016 in Human Mutation
Verified
Journal Article
Closed access
PDF file
LBLiacine Bouaoun
Liacine Bouaoun
DSDmitriy Sonkin
Dmitriy Sonkin
MAMaude Ardin
Maude Ardin
MHMonica Hollstein
Monica Hollstein
GBGraham Byrnes
Graham Byrnes
MOMagali Olivier
Magali Olivier

19 February 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JZJiri Zavadil
Jiri Zavadil
LCLukas Cermak
Lukas Cermak
NSNoemi Soto‐Nieves
Noemi Soto‐Nieves
EBErwin P Böttinger
Erwin P Böttinger
Epithelial‐to‐mesenchymal transitions (EMTs) underlie cell plasticity required in embryonic development and frequently observed in advanced carcinogenesis. Transforming growth factor‐β (TGF‐β) induces EMT phenotypes in epithelial cells in vitro and has been associated with EMT in vivo . Here we report that expression of the hairy/enhancer‐of‐split‐related transcriptional repressor Hey1, and the Notch‐ligand Jagged1 (Jag1), was induced by TGF‐β at the onset of EMT in epithelial cells from mammary gland, kidney tubules, and epidermis. The HEY1 expression profile was biphasic, consisting of immediate‐early Smad3‐dependent, Jagged1/Notch‐independent activation, followed by delayed, indirect Jagged1/Notch‐dependent activation. TGF‐β‐induced EMT was blocked by RNA silencing of HEY1 or JAG1 , and by chemical inactivation of Notch. The EMT phenotype, biphasic activation of Hey1 , and delayed expression of Jag1 were induced by TGF‐β in wild‐type, but not in Smad3‐deficient, primary mouse kidney tubular epithelial cells. Our findings identify a new mechanism for functional integration of Jagged1/Notch signalling and coordinated activation of the Hey1 transcriptional repressor controlled by TGF‐β/Smad3, and demonstrate functional roles for Smad3, Hey1, and Jagged1/Notch in mediating TGF‐β‐induced EMT.